129 related articles for article (PubMed ID: 37302442)
1. The Clinical Impact and Cost-Effectiveness of Surveillance of Incidentally Detected Gastric Intestinal Metaplasia: A Microsimulation Analysis.
Thiruvengadam NR; Gupta S; Buller S; Awad I; Gandhi D; Ibarra A; Latorre G; Riquelme A; Kochman ML; Cote G; Shah SC; Saumoy M
Clin Gastroenterol Hepatol; 2024 Jan; 22(1):51-61. PubMed ID: 37302442
[TBL] [Abstract][Full Text] [Related]
2. Biennial Endoscopic Surveillance of Gastrointestinal Metaplasia and Its Subtypes Reduces Gastric Cancer Mortality and Is Cost-Effective in a Markov State Transition Model.
Becker EC; Salunke R; Saraceni C; Birk J
South Med J; 2023 Dec; 116(12):951-956. PubMed ID: 38051169
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival.
Yeh JM; Ho W; Hur C
Gastrointest Endosc; 2010 Jul; 72(1):33-43. PubMed ID: 20430384
[TBL] [Abstract][Full Text] [Related]
4. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
[TBL] [Abstract][Full Text] [Related]
5. Adequacy of endoscopic recognition and surveillance of gastric intestinal metaplasia and atrophic gastritis: A multicentre retrospective study in low incidence countries.
Honing J; Keith Tan W; Dieninyte E; O'Donovan M; Brosens L; Weusten B; di Pietro M
PLoS One; 2023; 18(6):e0287587. PubMed ID: 37352223
[TBL] [Abstract][Full Text] [Related]
6. Gastric intestinal metaplasia - age, ethnicity and surveillance for gastric cancer.
Simko V; Anand N; Ginter E
Bratisl Lek Listy; 2015; 116(1):3-8. PubMed ID: 25666954
[TBL] [Abstract][Full Text] [Related]
7. The risk of gastric cancer in patients with gastric intestinal metaplasia in 5-year follow-up.
Pittayanon R; Rerknimitr R; Klaikaew N; Sanpavat A; Chaithongrat S; Mahachai V; Kullavanijaya P; Barkun A
Aliment Pharmacol Ther; 2017 Jul; 46(1):40-45. PubMed ID: 28449219
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer.
Yeh JM; Hur C; Kuntz KM; Ezzati M; Goldie SJ
Cancer; 2010 Jun; 116(12):2941-53. PubMed ID: 20564399
[TBL] [Abstract][Full Text] [Related]
9. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.
Saumoy M; Schneider Y; Shen N; Kahaleh M; Sharaiha RZ; Shah SC
Gastroenterology; 2018 Sep; 155(3):648-660. PubMed ID: 29778607
[TBL] [Abstract][Full Text] [Related]
10. Clinical epidemiology and outcomes of patients with gastric intestinal metaplasia in the Los Angeles County System.
Prakash P; Jain S; Trieu H; Chow K; Karunasiri D; Liang T; Yung E; Mason H; Tan H; Tabibian JH
BMC Gastroenterol; 2023 May; 23(1):165. PubMed ID: 37208616
[TBL] [Abstract][Full Text] [Related]
11. Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study.
Huang HL; Leung CY; Saito E; Katanoda K; Hur C; Kong CY; Nomura S; Shibuya K
BMC Med; 2020 Sep; 18(1):257. PubMed ID: 32921305
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia.
Hassan C; Zullo A; Di Giulio E; Annibale B; Lahner E; De Francesco V; Ierardi E
Helicobacter; 2010 Jun; 15(3):221-6. PubMed ID: 20557364
[TBL] [Abstract][Full Text] [Related]
13. Risk of Gastric Cancer Among Patients With Intestinal Metaplasia of the Stomach in a US Integrated Health Care System.
Reddy KM; Chang JI; Shi JM; Wu BU
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1420-5. PubMed ID: 27317852
[TBL] [Abstract][Full Text] [Related]
14. Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States.
Shah SC; Canakis A; Peek RM; Saumoy M
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3026-3039. PubMed ID: 32707341
[TBL] [Abstract][Full Text] [Related]
15. Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions.
Wu JT; Zhou J; Naidoo N; Yang WY; Lin XC; Wang P; Ding JQ; Wu CB; Zhou HJ
Asia Pac J Clin Oncol; 2016 Dec; 12(4):359-368. PubMed ID: 27452189
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Extensive and Limited Gastric Intestinal Metaplasia and Progression to Dysplasia and Gastric Cancer.
Laszkowska M; Truong H; Faye AS; Kim J; Tan SX; Lim F; Abrams JA; Hur C
Dig Dis Sci; 2022 Aug; 67(8):3693-3701. PubMed ID: 34657192
[TBL] [Abstract][Full Text] [Related]
17. How Do We Manage Gastric Intestinal Metaplasia? A Survey of Clinical Practice Trends for Gastrointestinal Endoscopists in the United States.
Vance RB; Kubiliun N; Dunbar KB
Dig Dis Sci; 2016 Jul; 61(7):1870-8. PubMed ID: 26984230
[TBL] [Abstract][Full Text] [Related]
18. Index diagnoses of gastric intestinal metaplasia in the United States: patient characteristics, endoscopic findings, and clinical practice patterns at a large tertiary care center.
Parbhu SK; Shah SC; Sossenheimer MJ; Fang JC; Peterson KA; Gawron AJ
Therap Adv Gastroenterol; 2022; 15():17562848221117640. PubMed ID: 36082176
[TBL] [Abstract][Full Text] [Related]
19. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events.
Sehested TSG; Bjerre J; Ku S; Chang A; Jahansouz A; Owens DK; Hlatky MA; Goldhaber-Fiebert JD
JAMA Cardiol; 2019 Feb; 4(2):128-135. PubMed ID: 30649147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
